XML 70 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interests [Member]
Foreign Exchange Contract [Member]
Foreign Exchange Contract [Member]
Accumulated Other Comprehensive Loss [Member]
Foreign Exchange Contract [Member]
Noncontrolling Interests [Member]
Interest Rate Swap [Member]
Interest Rate Swap [Member]
Accumulated Other Comprehensive Loss [Member]
Balance, beginning of period, preferred shares (in shares) at Dec. 31, 2016   0                    
Balance at beginning of period at Dec. 31, 2016 $ 2,343.1 $ 0.0 $ 0.0 $ 1,231.4 $ (112.2) $ (71.2) $ 1,295.1          
Balance, beginning of period, common shares (in shares) at Dec. 31, 2016     115,740,906                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Stock issuance (in shares)     37,226,695                  
Stock issuance (823.2)     680.7   (358.4) (1,145.5)          
Shares forfeited (in shares)     (57,000)                  
Restricted stock grants (RSG) (in shares)     1,756,750                  
Shares retired due to RSG Vesting (in shares)     (1,460,251)                  
Shares retired due to RSG Vesting (37.9)     (37.9)                
Shares retired due to common stock repurchase program (in shares)     (1,645,816)                  
Shares retired due to common stock repurchase program (29.9)     (29.1) (0.8)              
Stock based compensation 38.2     38.2                
Other comprehensive income (loss):                        
Unrealized foreign currency translation (losses) gains, net of tax 158.4         52.0 106.4          
Unrealized foreign currency derivative contract gain, net of tax               $ (69.4) $ (49.7) $ (19.7)    
Unrealized losses on marketable securities 0.2         0.2            
Common stock dividends (87.4)       (87.4)              
Net income 138.0       100.5   37.5          
Acquisition of Kennedy Wilson Europe (KWE) shares from noncontrolling interest holders (3.3)           (3.3)          
Contributions from noncontrolling interests, excluding KWE 47.4           47.4          
Distributions to noncontrolling interests (106.0)           (106.0)          
Balance, end of period, preferred shares (in shares) at Dec. 31, 2017   0                    
Balance at end of period at Dec. 31, 2017 1,577.5 $ 0.0 $ 0.0 1,883.3 (90.6) (427.1) 211.9          
Balance, end of period, common shares (in shares) at Dec. 31, 2017     151,561,284                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Shares forfeited (in shares)     (30,100)                  
Restricted stock grants (RSG) (in shares)     1,524,383                  
Shares retired due to RSG Vesting (in shares)     (486,032)                  
Shares retired due to RSG Vesting (8.8)     (8.8)                
Shares retired due to common stock repurchase program (in shares)     (9,364,141)                  
Shares retired due to common stock repurchase program     $ (169.1) (167.0) (2.1)              
Stock based compensation 37.1     37.1                
Other comprehensive income (loss):                        
Unrealized foreign currency translation (losses) gains, net of tax (44.2)         (47.5) 3.3          
Unrealized foreign currency derivative contract gain, net of tax               33.2 33.2      
Unrealized losses on marketable securities (0.1)         (0.1) 0.0          
Common stock dividends (113.7)       (113.7)              
Net income 212.1       150.0   62.1          
Contributions from noncontrolling interests, excluding KWE 23.2           23.2          
Distributions to noncontrolling interests (116.0)           (116.0)          
Balance, end of period, preferred shares (in shares) at Dec. 31, 2018   0                    
Balance at end of period at Dec. 31, 2018 $ 1,431.2 $ 0.0 $ 0.0 1,744.6 (56.4) (441.5) 184.5          
Balance, end of period, common shares (in shares) at Dec. 31, 2018 143,205,394   143,205,394                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Stock issuance (in shares)   300,000                    
Stock issuance $ 295.2 $ 295.2                    
Restricted stock grants (RSG) (in shares)     64,458                  
Shares retired due to RSG Vesting (in shares)     (764,909)                  
Shares retired due to RSG Vesting (16.4)     (16.4)                
Shares retired due to common stock repurchase program (in shares)     (221,834)                  
Shares retired due to common stock repurchase program     $ (4.3) (3.9) (0.4)              
Stock based compensation 30.2     30.2                
Other comprehensive income (loss):                        
Unrealized foreign currency translation (losses) gains, net of tax 6.3         (4.3) 10.6          
Unrealized currency derivative contract gain (loss) (0.7)             $ 29.3 $ 29.3   $ (0.7) $ (0.7)
Common stock dividends (121.1)       (121.1)              
Preferred stock dividends (2.6)                      
Net income 321.1       226.7   94.4          
Contributions from noncontrolling interests, excluding KWE 15.0           15.0          
Distributions to noncontrolling interests $ (264.0)           (264.0)          
Balance, end of period, preferred shares (in shares) at Dec. 31, 2019 300,000 300,000                    
Balance at end of period at Dec. 31, 2019 $ 1,719.2 $ 295.2 $ 0.0 $ 1,754.5 $ 46.2 $ (417.2) $ 40.5          
Balance, end of period, common shares (in shares) at Dec. 31, 2019 142,283,109   142,283,109